SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19242075
Source:
http://linkedlifedata.com/resource/pubmed/id/19242075
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0020538
,
umls-concept:C0032893
,
umls-concept:C0087111
,
umls-concept:C0205210
,
umls-concept:C0205225
,
umls-concept:C0248719
,
umls-concept:C0332173
,
umls-concept:C0392760
,
umls-concept:C1521761
pubmed:issue
1
pubmed:dateCreated
2009-2-26
pubmed:abstractText
Telmisartan provides effective treatment of hypertension in a broad spectrum of patients. Aims: To evaluate factors affecting the efficacy of telmisartan in daily clinical practice.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2985196R
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoates
,
http://linkedlifedata.com/resource/pubmed/chemical/telmisartan
pubmed:status
MEDLINE
pubmed:issn
0022-3859
pubmed:author
pubmed-author:BergovacMM
,
pubmed-author:Knezevi?AA
,
pubmed-author:PlavecDD
,
pubmed-author:TrkuljaVV
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27-32
pubmed:meshHeading
pubmed-meshheading:19242075-Adult
,
pubmed-meshheading:19242075-Aged
,
pubmed-meshheading:19242075-Aged, 80 and over
,
pubmed-meshheading:19242075-Angiotensin II Type 1 Receptor Blockers
,
pubmed-meshheading:19242075-Antihypertensive Agents
,
pubmed-meshheading:19242075-Arteries
,
pubmed-meshheading:19242075-Benzimidazoles
,
pubmed-meshheading:19242075-Benzoates
,
pubmed-meshheading:19242075-Blood Pressure
,
pubmed-meshheading:19242075-Female
,
pubmed-meshheading:19242075-Humans
,
pubmed-meshheading:19242075-Hypertension
,
pubmed-meshheading:19242075-Male
,
pubmed-meshheading:19242075-Middle Aged
,
pubmed-meshheading:19242075-Multivariate Analysis
,
pubmed-meshheading:19242075-Prospective Studies
,
pubmed-meshheading:19242075-Risk Factors
,
pubmed-meshheading:19242075-Treatment Outcome
pubmed:articleTitle
Telmisartan in daily clinical practice: factors affecting efficacy in treatment of primary arterial hypertension.
pubmed:affiliation
Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia.
pubmed:publicationType
Journal Article
,
Multicenter Study